Molecular Farming of Pembrolizumab and Nivolumab

Immune checkpoint inhibitors (ICIs) are a class of immunotherapy agents capable of alleviating the immunosuppressive effects exerted by tumorigenic cells. The programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) immune checkpoint is one of the most ubiquitous checkpoints utilized...

Descripción completa

Detalles Bibliográficos
Autores principales: Stark, Michael C., Joubert, Anna M., Visagie, Michelle H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298108/
https://www.ncbi.nlm.nih.gov/pubmed/37373192
http://dx.doi.org/10.3390/ijms241210045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298108/
https://www.ncbi.nlm.nih.gov/pubmed/37373192
http://dx.doi.org/10.3390/ijms241210045

Ejemplares similares